Silence Therapeutics • SLN
Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Craig A. Tooman$1.1B
Market Cap • 25/04/20241994
(há 30 anos)
2020
(4 years ago)
NASDAQ
Listagem
London
122
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
SLNSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.